Therapeutic benefits of delayed lithium administration in the neonatal rat after cerebral hypoxia-ischemia

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Xie, Cuicui ^a,b   Zhou, Kai ^a,b   Wang, Xiaoyang ^a,c   Blomgren, Klas ^a,b,d   Zhu, Changlian ^a,c,e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c ZHENGZHOU UNIVERSITY   (China)

^d QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^e ZHENGZHOU CHILDREN S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LITHIUM CHLORIDE; CYTOKINE; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN WEIGHT; CELL ACTIVATION; CELL DEATH; CORPUS STRIATUM; CREATININE BLOOD LEVEL; DENTATE GYRUS; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; HIPPOCAMPUS; HYPERACTIVITY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; MALE; MICROGLIA; MOTOR ACTIVITY; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; THALAMUS; THERAPY DELAY; TREATMENT DURATION; ANIMAL; APOPTOSIS; BLOOD; DRUG EFFECTS; HYPOXIA-ISCHEMIA, BRAIN; NERVOUS SYSTEM DEVELOPMENT; NEWBORN; PATHOLOGY;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CYTOKINES; HYPOXIA-ISCHEMIA, BRAIN; LITHIUM CHLORIDE; MALE; NEUROGENESIS; NEUROPROTECTIVE AGENTS; RATS;

EID: 84929689242     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107192     Document Type: Article

References (39)

1. Lawn JE, Bahl R, Bergstrom S, Bhutta ZA, Darmstadt GL, et al. (2011) Setting research priorities to reduce almost one million deaths from birth asphyxia by 2015. PLoS Med 8: e1000389.
2. Mwaniki MK, Atieno M, Lawn JE, Newton CR (2012) Long-term neurode-velopmental outcomes after intrauterine and neonatal insults: a systematic review. Lancet 379: 445-452.
3. Hagberg H, Mallard C, Rousset CI, Xiaoyang W (2009) Apoptotic mechanisms in the immature brain: involvement of mitochondria. J Child Neurol 24: 1141-1146.
4. Perrone S, Stazzoni G, Tataranno ML, Buonocore G (2012) New pharmaco-logic and therapeutic approaches for hypoxic-ischemic encephalopathy in the newborn. J Matern Fetal Neonatal Med 25 Suppl 1: 83-88.
5. Johnston MV, Fatemi A, Wilson MA, Northington F (2011) Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 10: 372-382.
6. Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, et al. (2012) Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 366: 2085-2092.
7. Drury PP, Bennet L, Gunn AJ (2010) Mechanisms of hypothermic neuroprotection. Semin Fetal Neonatal Med 15: 287-292.
8. Zhu C, Wang X, Xu F, Bahr BA, Shibata M, et al. (2005) The influence of age on apoptotic and other mechanisms of cell death after cerebral hypoxia-ischemia. Cell Death Differ 12: 162-176.
9. Wang X, Karlsson JO, Zhu C, Bahr BA, Hagberg H, et al. (2001) Caspase-3 activation after neonatal rat cerebral hypoxia-ischemia. Biol Neonate 79: 172-179.
10. Geddes R, Vannucci RC, Vannucci SJ (2001) Delayed cerebral atrophy following moderate hypoxia-ischemia in the immature rat. Dev Neurosci 23: 180-185.
11. Winerdal M, Winerdal ME, Kinn J, Urmaliya V, Winqvist O, et al. (2012) Long lasting local and systemic inflammation after cerebral hypoxic ischemia in newborn mice. PLoS One 7: e36422.
12. Wideroe M, Brekken C, Kavelaars A, Pedersen TB, Goa PE, et al. (2011) Longitudinal manganese-enhanced magnetic resonance imaging of delayed brain damage after hypoxic-ischemic injury in the neonatal rat. Neonatology 100: 363-372.
13. Dzietko M, Derugin N, Wendland MF, Vexler ZS, Ferriero DM (2013) Delayed VEGF Treatment Enhances Angiogenesis and Recovery After Neonatal Focal Rodent Stroke. Transl Stroke Res 4: 189-200.
14. van Velthoven CT, Kavelaars A, van Bel F, Heijnen CJ (2010) Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 30: 9603-9611.
15. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, et al. (2009) Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalop-athy. Pediatrics 124: e218-226.
16. Jenkins DD, Rollins LG, Perkel JK, Wagner CL, Katikaneni LP, et al. (2012) Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. J Cereb Blood Flow Metab 32: 1888-1896.
17. Fleiss B, Gressens P (2012) Tertiary mechanisms of brain damage: a new hope for treatment of cerebral palsy? Lancet Neurol 11: 556-566.
18. Malhi GS, Tanious M, Das P, Coulston CM, Berk M (2013) Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs 27: 135-153.
19. Licht RW (2012) Lithium: still a major option in the management of bipolar disorder. CNS Neurosci Ther 18: 219-226.
20. Li Q, Li H, Roughton K, Wang X, Kroemer G, et al. (2010) Lithium reduces apoptosis and autophagy after neonatal hypoxia-ischemia. Cell Death Dis 1: 1-9.
21. Li H, Li Q, Du X, Sun Y, Wang X, et al. (2011) Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiin-flammatory effects and enhanced proliferation and survival of neural stem/progenitor cells. J Cereb Blood Flow Metab 31: 2106-2115.
22. Contestabile A, Greco B, Ghezzi D, Tucci V, Benfenati F, et al. (2013) Lithium rescues synaptic plasticity and memory in Down syndrome mice. J Clin Invest 123: 348-361.
23. Chuang DM, Wang Z, Chiu CT (2011) GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke. Front Mol Neurosci 4: 15.
24. Camins A, Verdaguer E, Junyent F, Yeste-Velasco M, Pelegri C, et al. (2009) Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium. CNS Neurosci Ther 15: 333-344.
25. Lee KY, Koh SH, Noh MY, Park KW, Lee YJ, et al. (2007) Glycogen synthase kinase-3beta activity plays very important roles in determining the fate of oxidative stress-inflicted neuronal cells. Brain Res 1129: 89-99.
26. Huo K, Sun Y, Li H, Du X, Wang X, et al. (2012) Lithium reduced neural progenitor apoptosis in the hippocampus and ameliorated functional deficits after irradiation to the immature mouse brain. Mol Cell Neurosci 51: 32-42.
27. Karperien A, Ahammer H, Jelinek HF (2013) Quantitating the subtleties of microglial morphology with fractal analysis. Front Cell Neurosci 7: 3.
28. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, et al. (2010) Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 375: 1969-1987.
29. Ren M, Senatorov VV, Chen RW, Chuang DM (2003) Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model. Proc Natl Acad Sci U S A 100: 6210-6215.
30. Xu J, Culman J, Blume A, Brecht S, Gohlke P (2003) Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death. Stroke 34: 1287-1292.
31. Yan XB, Wang SS, Hou HL, Ji R, Zhou JN (2007) Lithium improves the behavioral disorder in rats subjected to transient global cerebral ischemia. Behav Brain Res 177: 282-289.
32. Zhu C, Wang X, Huang Z, Qiu L, Xu F, et al. (2007) Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. Cell Death Differ 14: 775-784.
33. Wang X, Stridh L, Li W, Dean J, Elmgren A, et al. (2009) Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 183: 7471-7477.
34. Doverhag C, Hedtjarn M, Poirier F, Mallard C, Hagberg H, et al. (2010) Galectin-3 contributes to neonatal hypoxic-ischemic brain injury. Neurobiol Dis 38: 36-46.
35. Leonardo CC, Pennypacker KR (2009) Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury. J Neuroinflammation 6: 13.
36. Qiu L, Zhu C, Wang X, Xu F, Eriksson PS, et al. (2007) Less neurogenesis and inflammation in the immature than in the juvenile brain after cerebral hypoxia-ischemia. J Cereb Blood Flow Metab 27: 785-794.
37. Zhu C, Qiu L, Wang X, Xu F, Nilsson M, et al. (2009) Age-dependent regenerative responses in the striatum and cortex after hypoxia-ischemia. J Cereb Blood Flow Metab 29: 342-354.
38. Zarruk JG, Fernandez-Lopez D, Garcia-Yebenes I, Garcia-Gutierrez MS, Vivancos J, et al. (2012) Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection. Stroke 43: 211-219.
39. Findling RL, Kafantaris V, Pavuluri M, McNamara NK, McClellan J, et al. (2011) Dosing strategies for lithium monotherapy in children and adolescents with bipolar I disorder. J Child Adolesc Psychopharmacol 21: 195-205.